Introduction
The 4th International AIDS Malignancy Conference, sponsored by the US National Cancer Institute (NCI), opened with a discussion of the current statistics related to HIV/AIDS around the world. As presented by Ellen Feigal, MD,[1] 33.6 million people had been diagnosed with AIDS worldwide by the end of 1999, with a total of 16.3 million deaths. New HIV infections reached 5.6 million worldwide in 1999 alone, with over 15,000 new infections per day. AIDS now causes 19% of all deaths in sub-Saharan Africa, and 4.2% of all deaths globally. It is within this setting that the current conference was convened, for the purposes of assessing the current state of our knowledge regarding the malignancies associated with HIV, and documenting any changes that may have occurred over time, with the use of highly active antiretroviral therapy (HAART), or both.
Made possible by an unrestricted educational grant from Ligand Pharmaceuticals.
Medscape HIV/AIDS eJournal. 2000;6(3) © 2000 Medscape
Comments